Leonardo Polizeli | Biology and Life Sciences | Best Research Article Award

Published on by Research Hypothesis

Ms. Leonardo Polizeli | Biology and Life Sciences | Best Research Article Award

Ms. Leonardo Polizeli | Biology and Life Sciences | Student| Federal University of Parana | Brazil

Ms. Leonardo Polizeli is a zoologist and entomology researcher with a strong academic foundation and growing contributions to insect systematics and Neotropical biodiversity studies. She completed her undergraduate education in Biological Sciences at Universidade Federal do Paraná, where she developed early research experience through scientific initiation programs, teaching-related scholarships, and academic extension activities. She later earned a Master’s degree in Biological Sciences with a specialization in Zoology (Entomology) from the same institution, supported by a national research scholarship, and conducted advanced research under expert supervision in insect taxonomy. Her professional experience includes active engagement at the Department of Zoology, Universidade Federal do Paraná, where she has contributed as a postgraduate researcher, scientific initiation scholar, academic volunteer, and student representative, demonstrating both research competence and institutional leadership. Ms. Leonardo Polizeli’s research interests center on the taxonomy, systematics, and classification of Blattaria (Blattodea), with particular emphasis on Blaberidae, Blaberinae, Zetoborinae, Neotropical cockroach diversity, and Araucaria forest ecosystems. Her work contributes to the understanding of insect biodiversity, evolutionary relationships, and conservation-relevant systematics within South American fauna.

Citation Metrics (Scopus)

5

4

3

2

1

0

Citations
4

i10index
3

h-index
1
🟦 Citations       🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

On the taxonomic status of two giant cockroaches of Bionoblatta (Blattodea, Blaberidae) collected by José Pinto da Fonseca, a founder of the Brazilian Society of Entomology – Journal of Orthoptera Research, Open Access

Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award | MD | Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished radiologist and internationally respected leader in breast imaging, currently serving as Professor and Vice Chair for Breast Imaging in the Department of Diagnostic, Molecular, and Interventional Radiology at the Icahn School of Medicine at Mount Sinai, where she has made transformative contributions to breast cancer detection, digital imaging, and women’s health. Dr. Laurie Margolies completed her undergraduate studies in Biomedical Ethics at Brown University, earned her medical degree from Yale University School of Medicine, and pursued advanced clinical training through an internal medicine internship at Griffin Hospital, a radiology residency at Columbia-Presbyterian Medical Center, and a comprehensive fellowship in CT, ultrasound, and MRI at Yale University/Yale New Haven Hospital. Her professional experience spans decades of academic appointments, including Instructor at Yale, rising through faculty ranks at Mount Sinai from Assistant Professor to full Professor, while simultaneously serving as System Chief of Breast Imaging across multiple hospitals, Director of Breast Imaging at Mount Sinai Hospital, and Chief of Breast Imaging at the Dubin Breast Center. Dr. Laurie Margolies’s research interests center on breast cancer screening optimization, digital mammography, cardiovascular risk evaluation through mammographic arterial calcifications, health disparity reduction, culturally targeted education programs, imaging physics, AI-driven diagnostic tools, and cross-disciplinary cancer detection methods. Her research skills include expertise in multimodality breast imaging, tomosynthesis assessment, radiologic quality control, population-based screening program development, clinical guideline evaluation, and participation in collaborative research teams across oncology, epidemiology, psychology, and medical physics. She has contributed to impactful studies published in reputable journals such as the Journal of Breast Imaging, Clinical Imaging, Journal of Cancer Education, and PEC Innovation, and she has served on multiple advisory boards for leading medical technology companies, advancing AI-assisted imaging development. Dr. Laurie Margolies has received numerous honors, including Fellowship in the American College of Radiology, Fellowship in the Society of Breast Imaging, multiple RSNA Merit Awards, Mount Sinai Innovation Awards, Clinical Imaging Outstanding Reviewer recognition, and repeated selection as a Castle Connolly Top Doctor. She has served on key institutional committees, leadership panels, and mentoring programs, significantly shaping radiologic quality improvement and cancer screening strategies. Dr. Laurie Margolies continues to influence clinical practice through her dedication to research, patient-centered care, and educational advancement, embodying excellence in academic radiology and demonstrating ongoing potential to elevate global breast imaging standards.

Profile: ORCID | Google Scholar

Featured Publications 

  1. Margolies, L. R., Spear, G. G., Payne, J. I., Iles, S. E., & Abdolell, M. (2025). Artificial intelligence for assessment of digital mammography positioning reveals persistent challenges.

  2. Rossi, J., Cho, L., Newell, M. S., Venta, L. A., Montgomery, G. H., Destounis, S. V., Brem, R. F., Parghi, C., & Margolies, L. R. (2025). Breast arterial calcifications on mammography: A review of the literature.

  3. Mullen, L. A., Ambinder, E. B., Talati, N., & Margolies, L. R. (2023). Mammography information systems: A survey of breast imaging radiologist satisfaction and perspectives.

  4. Head, K. J., Harrington, N. G., Schnur, J. B., Margolies, L., & Montgomery, G. H. (2022). Examining gain- and loss-framed messages in a novel breast cancer screening/cardiovascular context: Does framing matter.

  5. Vang, S., Margolies, L. R., & Jandorf, L. (2022). Screening mammogram adherence in medically underserved women: Does language preference matter.

  6. Fung, J., Vang, S., Margolies, L. R., Li, A., Blondeau-Lecomte, E., Li, A., & Jandorf, L. (2021). Developing a culturally and linguistically targeted breast cancer educational program for a multicultural population.

  7. Margolies, L. R., Salvatore, M., Yip, R., Tam, K., Bertolini, A., Henschke, C., & Yankelevitz, D. (2018). The chest radiologist’s role in invasive breast cancer detection.

 

Zeinab Mohsenipour | Biology and Life Sciences | Women Researcher Award

Published on by Research Hypothesis

Dr. Zeinab Mohsenipour | Biology and Life Sciences | Women Researcher Award

Dr. Zeinab Mohsenipour | Biology and Life Sciences | Women Researcher Award | Postdoctoral Researcher | Tehran University of Medical Sciences | Iran

Dr. Zeinab Mohsenipour is a distinguished Iranian microbiologist whose scholarly focus and scientific achievements have advanced the field of Medical Bacteriology, particularly in the areas of antimicrobial resistance, bacterial biofilms, and bacteriophage therapy. She earned her Ph.D. in Medical Bacteriology from Tehran University of Medical Sciences, building on her earlier academic foundation with an M.Sc. in Microbiology and a B.A. in Biology from Shahid Bahonar University of Kerman. Throughout her academic and research journey, Dr. Mohsenipour has demonstrated an unwavering commitment to exploring the molecular and clinical mechanisms underlying infectious diseases. Her professional experience encompasses serving as a Research Assistant in the Bacteriology Laboratory at Tehran University of Medical Sciences and as a Lecturer at the University of Science and Culture, where she has taught undergraduate courses in microbial physiology, medical bacteriology, and microbial diversity. Beyond academia, she has also held an industry leadership role as Sales Manager at NojanTeb Azma Company, gaining practical insight into the intersection of scientific innovation and healthcare product development. Her research interests center on the study of antibiotic-resistant pathogens, biofilm inhibition, natural antimicrobial compounds, and the therapeutic application of predatory bacteria and bacteriophages. Dr. Mohsenipour possesses an extensive range of research skills, including bacterial culture and identification, PCR and molecular cloning, antibiotic susceptibility testing, and animal model experimentation, all of which contribute to her capacity for translational biomedical research. Her scientific productivity is evidenced by her numerous peer-reviewed publications in reputable journals indexed in Scopus, Frontiers, and BMC, addressing urgent microbiological issues such as lung infection models and bacterial-based drug delivery systems. Dr. Mohsenipour has also co-authored scientific books that enrich microbiological education, including An Overview of Monoclonal Antibodies: Production Methods and Applications and The Principle of Microbial Physiology. Her contributions have been recognized through invitations to serve as a reviewer for the European Journal of Clinical and Biomedical Sciences and through memberships in esteemed professional societies such as the American Society for Microbiology (ASM) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Dr. Mohsenipour’s excellence in both teaching and research reflects her passion for nurturing scientific inquiry and innovation. Her continuous involvement in international collaborations, advanced workshops, and cutting-edge bacteriological projects underscores her role as a promising and impactful researcher who is shaping the future of microbial science and global health improvement.

Profile: Scopus | ORCID | Google Scholar

Featured Publications 

  1. Mohsenipour, Z., & Hassanshahian, M. (2015). The inhibitory effect of Thymus vulgaris extracts on the planktonic form and biofilm structures of six human pathogenic bacteria. Avicenna Journal of Phytomedicine, 5(4), 309–318. (Citations: 94)

  2. Mohsenipour, Z., & Hassanshahian, M. (2015). The effects of Allium sativum extracts on biofilm formation and activities of six pathogenic bacteria. Jundishapur Journal of Microbiology, 8(8), e18971. (Citations: 78)

  3. Mohsenipour, Z., & Hassanshahian, M. (2016). Antibacterial activity of Euphorbia hebecarpa alcoholic extracts against six human pathogenic bacteria in planktonic and biofilm forms. Jundishapur Journal of Microbiology, 9(6), e34701. (Citations: 63)

  4. Omidinia, E., Shahbazmohammadi, H., & Mohsenipour, Z. (2019). Partitioning of recombinant Pseudomonas putida POS-F84 proline dehydrogenase in aqueous two-phase systems: Optimization using response surface methodology. Applied Biochemistry and Biotechnology, 189, 498–510. (Citations: 32)

  5. Tajabadi, F. H., Karimian, S. M., Mohsenipour, Z., et al. (2022). Biocontrol treatment: Application of Bdellovibrio bacteriovorus HD100 against burn wound infection caused by Pseudomonas aeruginosa in mice. Burns: Journal of the International Society for Burn Injuries. (Citations: 19)

  6. Mohsenipour, Z., Arazi, P., Skurnik, M., et al. (2024). Predation on bacterial pathogens by predatory bacteria of sewage origin: Three days prey-predator interactions. BMC Microbiology, 24, 516. (Citations: 12)

  7. Mohsenipour, Z., Kianian, F., Jahanbin, B., Abtahi, H. R., Ghazanfari, T., Edalatifard, M., Amanpour, S., Skurnik, M., Arazi, P., & Feizabadi, M. M. (2025). Predatory bacteria can intensify lung injury in a multidrug-resistant Acinetobacter baumannii pneumonia model in rat. Frontiers in Microbiology, 16, 1512119. (Citations: 7)

 

Paola Pontrelli | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

Assoc. Prof. Dr. Paola Pontrelli | Biology and Life Sciences | Best Researcher Award

Biology and Life Sciences | University of Bari Aldo Moro | Italy

Assoc. Prof. Dr. Paola Pontrelli is a female scientist specializing in experimental biology with emphasis on renal pathophysiology, transplantation immunology, and molecular mechanisms in kidney disease. She holds a PhD in clinical pathology / experimental biology from the University of Bari Aldo Moro and/or affiliated institutions (PhD granted after high-quality doctoral work in molecular and immunologic mechanisms underlying renal injury, graft rejection, and kidney transplantation). Over her academic and professional career she has held roles such as Associate Professor in the Department of Biomedical Sciences / Experimental Biology, has been involved in major research units at the University of Bari and related transplant and nephrology centers, and has collaborated extensively at national and international levels, participating in multidisciplinary projects on dialysis, graft rejection, bio-molecular profiling, immune signalling, complement activation and chronic kidney disease. Her work draws on strong research interests including diabetic nephropathy, antibody-mediated rejection of kidney transplants, inflammation and immune modulation in dialysis and transplant settings, interferon signatures, metabolic dysregulation in immune cells, and molecular biomarker discovery. She has developed research skills in transcriptomics / gene expression profiling, proteomics / phosphoproteome analyses, flow cytometry, immunohistochemistry, Western blot, microarray, quantitative PCR, bioinformatic pathway analysis, handling patient samples (dialysis, transplant) and in vitro/in vivo experimental models. Assoc. Prof. Dr. Paola Pontrelli has authored 97 documents, 2,676 Citations, 30 h-index, reflecting a robust scholarly output and impact.

Profile:  Scopus | ORCID

Featured Publications

  1. “Dialysis-related systemic microinflammation is associated with specific genomic patterns”, 2008 — ~31 citations

  2. “Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells”, 2015 — ~64 citations

  3. “GENE EXPRESSION PROFILES IN CD8+ T CELLS IN CHRONIC ANTIBODY-MEDIATED REJECTION (CAMR) OF KIDNEY TRANSPLANTATION”, 2018 — citation

  4. “Plasma-derived extracellular vesicles from kidney transplant patients with antibody-mediated rejection induced endothelial-to-mesenchymal transition and senescence in tubular epithelial cells by modulating complement activation”, 2022 — citation

  5. “A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation”, 2015 — citation

 

Shouping Xu | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

Assoc. Prof. Dr. Shouping Xu | Biology and Life Sciences | Best Researcher Award

Assoc. Prof. Dr. Shouping Xu | Biology and Life Sciences | Medical Physicist | Cancer Hospital Chinese Academy of Medical Sciences | China

Assoc. Prof. Dr. Shouping Xu is a distinguished medical physicist specializing in radiation oncology, with extensive expertise in advanced radiotherapy techniques and the integration of artificial intelligence in cancer treatment. He holds degrees in nuclear physics and medical physics from leading Chinese institutions and has served in senior leadership roles as Chief Clinical Medical Physicist at the Cancer Hospital, Chinese Academy of Medical Sciences, and previously at the Chinese PLA General Hospital and Yi Zhou Proton Therapy Center. Assoc. Prof. Dr. Shouping Xu  has made significant contributions to the development of innovative dose prediction models, proton therapy planning, and image-guided radiotherapy, with numerous publications in high-impact international journals. His active engagement in global conferences, memberships in professional societies, and certifications from recognized boards reflect his commitment to advancing medical physics. Widely respected for both his clinical leadership and research excellence, Assoc. Prof. Dr. Shouping Xu continues to play a key role in shaping the future of precision radiotherapy and medical imaging technologies.

Professional Profile 

Education  

Assoc. Prof. Dr. Shouping Xu has a strong academic background in physics and medical physics, beginning with a Bachelor of Science degree in Nuclear Physics Technology from Lanzhou University, China. He went on to pursue advanced studies at Tsinghua University, where he earned a Master of Science degree in Medical Physics from the Department of Engineering Physics, followed by a Doctor of Philosophy in Medical Physics from the same department. His education provided a solid foundation in radiation physics, imaging, and advanced treatment technologies, which has been central to his career in radiation oncology and his contributions to clinical innovation and research in medical physics.

Professional Experience

Assoc. Prof. Dr. Shouping Xu has built an extensive professional career in medical physics, holding key clinical and leadership positions in some of China’s most renowned cancer treatment centers. He currently serves as Chief Clinical Medical Physicist at the Proton Center of the Cancer Hospital, Chinese Academy of Medical Sciences, where he oversees clinical operations, quality management, and research in advanced radiotherapy. Previously, he was Chief Medical Physicist and Vice Director at the Yi Zhou Proton Therapy Center, where he played a pivotal role in establishing clinical workflows and implementing cutting-edge proton and photon therapies. Earlier in his career, he served at the Chinese PLA General Hospital as Chief and Senior Medical Physicist, contributing to innovations in IMRT, image-guided radiotherapy, and quality assurance. With responsibilities ranging from managing multidisciplinary teams to developing clinical protocols and engaging in pioneering research, Assoc. Prof. Dr. Shouping Xu has consistently demonstrated leadership, technical expertise, and a strong commitment to advancing radiation oncology practices.

Research Interest

Assoc. Prof. Dr. Shouping Xu’s research interests lie at the intersection of medical physics, radiation oncology, and artificial intelligence, with a focus on advancing precision radiotherapy. His work emphasizes the development of AI-driven algorithms and deep learning models for dose prediction, treatment planning, and image-guided radiotherapy, aiming to improve both the efficiency and accuracy of cancer treatment. He has conducted extensive studies on proton therapy, CyberKnife radiosurgery, and advanced techniques such as VMAT, IMRT, and adaptive radiotherapy, contributing to innovations in treatment optimization and quality assurance. Additionally, his research explores deformable image registration, dose verification, and the clinical application of AI for enhancing radiotherapy workflows. By bridging physics, engineering, and oncology, Assoc. Prof. Dr. Shouping Xu is committed to translating cutting-edge technologies into practical clinical tools that improve outcomes and safety for cancer patients.

Award and Honor

Assoc. Prof. Dr. Shouping Xu has earned recognition for his significant contributions to medical physics and radiation oncology through his active involvement in international conferences, professional societies, and research achievements. He has been an invited speaker and presenter at prestigious forums such as the AAPM Annual Meetings, the IUPESM World Congress on Medical Physics and Biomedical Engineering, and the Asia-Oceania Congress of Medical Physics, where his work on advanced radiotherapy techniques and AI-driven innovations has been highlighted. His leadership roles as Chief Clinical Medical Physicist and his certifications from the Chinese Board of Medical Physicists (CBMP) and the Chinese Board of Radiation Protection (CBRP) further underscore his professional excellence. Through his research, publications, and professional service, Assoc. Prof. Dr. Shouping Xu has gained both national and international recognition, reflecting his status as a highly respected figure in the field of medical physics.

Publications Top Noted

Dosimetric evaluation of intensity modulated proton therapy and photon volumetric modulated arc therapy for bilateral breast cancer
Year: 2025

Virtual-simulation boosted neural network dose calculation engine for intensity-modulated radiation therapy
Year: 2025

Dose rate correction of a diode array for universal wedge field dosimetric verification
Year: 2025

gMCAP: a GPU-based Monte Carlo proton transport program for high-density tissues with precise nuclear reaction models
Year: 2025

An AI dose-influence matrix engine for robust pencil beam scanning protons therapy
Year: 2025

A feasibility study of dose-band prediction in radiation therapy: Predicting a spectrum of plan dose
Year: 2025

A StarGAN and transformer-based hybrid classification-regression model for multi-institution VMAT patient-specific quality assurance
Year: 2025

Dose prediction of CyberKnife Monte Carlo plan for lung cancer patients based on deep learning: robust learning of variable beam configurations
Year: 2024

Dosimetric comparison of ZAP-X, Gamma Knife, and CyberKnife stereotactic radiosurgery for single brain metastasis
Year: 2024

Conclusion

Assoc. Prof. Dr. Shouping Xu is highly suitable for the Best Researcher Award. His combination of clinical leadership, innovative research in AI-driven radiation therapy, and active participation in international scientific forums positions him as a thought leader in medical physics and oncology. With his strong portfolio of publications and pioneering approaches to radiation therapy planning and quality assurance, he demonstrates both scientific excellence and clinical relevance. With further emphasis on international collaborations and translational outcomes, his contributions will continue to shape the future of precision radiotherapy.

Ian Dubery | Biology and Life Sciences | Excellence in Research Award

Published on by Research Hypothesis

Ian Dubery | Biology and Life Sciences | Excellence in Research Award

Prof Ian Dubery, University of Johannesburg, South Africa

Prof. Ian Dubery is a distinguished biochemist specializing in plant biochemistry, molecular biology, and agricultural biotechnology 🌱🔬. With a Ph.D. (cum laude) from Rand Afrikaans University, he has held esteemed roles, including Research Professor and Director of the Research Centre for Plant Metabolomics 🌾. His research focuses on plant-pathogen interactions, defense mechanisms, and metabolomics, boasting over 216 journal publications 📚✨. An NRF-rated scientist with an h-index of 52 (Google Scholar), he has supervised 50+ M.Sc. and 23 Ph.D. students 🎓. His accolades include the Boehringer Mannheim Prize and Alexander von Humboldt Foundation fellowships 🏆🌍.

Publication Profile

Orcid

Academic Background

Prof. Ian Dubery 🎓 earned all his academic qualifications in biochemistry with distinction (cum laude) from Rand Afrikaans University (RAU), Johannesburg, South Africa. He completed his B.Sc. in Biochemistry and Chemistry in 1975 🧪, followed by a B.Sc. Hons. in Biochemistry in 1976 📜. He achieved his M.Sc. in Biochemistry in 1981 🥼 and culminated his academic journey with a Ph.D. in Biochemistry in 1986 🧬. Prof. Dubery’s outstanding academic performance reflects his dedication and expertise in the field of biochemistry, laying the foundation for his illustrious career as a researcher and educator. 🌟

Awards and Recognition

Professor Ian Dubery, a distinguished scientist, has received numerous accolades throughout his career 🌟. He was the highest academic achiever in Biochemistry and Chemistry (1975) 🧪 and earned B.Sc. (1975) and B.Sc. Hons. (1976) degrees with top honors 🎓. His awards include the Boehringer Mannheim Prize 🏅, Alexander von Humboldt Fellowships 🇩🇪, and the SA Biochemical Society Gold Medal (2016) 🥇. A globally recognized researcher with an h-index of 52 📊, he has been an NRF-rated scientist since 1998 🔬. Recent achievements include the Hertzog Prize for Science & Technology (2024) and NSTF finalist recognition in 2020 🌍.

Experience

Prof. Ian Dubery has been a distinguished educator and researcher in biochemistry and molecular biology since 1982, teaching at the University of Johannesburg. 📚👨‍🏫 He has supervised 50 M.Sc. and 23 Ph.D. students, fostering academic growth. 🌟 As a scientist, he has contributed extensively, publishing 216+ articles in international journals. 📝🔬 His research collaborations span prestigious institutions, including the Max Planck Institute and Salk Institute. 🌍💡 With leadership roles as Chair of Biochemistry and committee memberships in ethics and research, he has excelled in academic management and scientific innovation. 🏢📈 Prof. Dubery remains a prominent figure in biochemical research. 🧬✨

Mentorship and Impact

Prof. Ian Dubery is a dedicated academic and mentor, shaping the next generation of scientists with excellence. 🌟 Over his illustrious career, he has supervised 50 M.Sc. and 23 Ph.D. students, guiding them toward impactful research and scientific achievements. 📚🔬 His mentorship emphasizes critical thinking, innovation, and scientific rigor, empowering students to excel in their respective fields. 🌱✨ With a passion for fostering academic growth and nurturing young talent, Prof. Dubery continues to inspire the scientific community. 🧪🎓 His legacy as an educator and mentor reflects his unwavering commitment to advancing knowledge and building future leaders in science. 🌍👏

Innovative Focus

Prof. Ian Dubery is a distinguished scholar in metabolomics, plant protection, and biochemistry, whose groundbreaking work addresses contemporary agricultural and environmental challenges. 🌱🔬 His research explores the intricate biochemical mechanisms in plants, advancing our understanding of their defense systems and resilience. 🌿🛡️ Prof. Dubery’s contributions have significant implications for sustainable agriculture and environmental conservation, providing innovative solutions to global challenges. 🌍💡 With numerous publications and impactful research, he remains a leading figure in the scientific community, inspiring advancements in plant sciences and beyond. 📚✨ His dedication to knowledge and innovation is shaping the future of agricultural sustainability. 🚜🌾

Research Focus

Prof. Ian A. Dubery’s research focuses on plant metabolomics, particularly in response to biotic stresses and defense mechanisms. His work integrates targeted metabolome and transcript profiling to understand plant chemical responses to pathogens like Pseudomonas syringae and Puccinia striiformis. He explores metabolite profiling of crops such as oats, sorghum, wheat, and barley, investigating the biochemical pathways triggered by infections and plant interactions with microorganisms. His studies contribute to improving plant resistance, understanding biosynthesis, and advancing crop protection strategies through the use of chemical and molecular profiling techniques. 🌱🔬🌾🧬

Publication Top Notes

Integration of targeted metabolome and transcript profiling of Pseudomonas syringae-triggered changes in defence-related phytochemicals in oat plants

Hordatines, dimerised hydroxycinnamoylagmatine conjugates of barley (Hordeum vulgare L.): an appraisal of the biosynthesis, chemistry, identification and bioactivities

Data-Driven Characterization of Metabolome Reprogramming during Early Development of Sorghum Seedlings

Exploration of chemical interactions between <i>Viscum combreticola</i> Engl. and its hosts through a metabolic profiling approach and molecular networking

Metabolite profiling of susceptible and resistant wheat (<i>Triticum aestivum</i>) cultivars responding to <i>Puccinia striiformis</i> f. sp. <i>tritici</i> infection